Fig. 6From: Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variantsImmune antigenicity of the scAAV5-RBD-plus vaccine in Wistar rats. A The scAAV5-RBD-plus vaccine strongly induced IgG production in rats; B NAs against wild-type SARS-COV-2 remained at a high level; C scAAV5-RBD-plus vaccine exhibited a high titer of NAs against variants Alpha, Beta, Gamma and Delta; D Body weights of rats increased steadily.Back to article page